JAMA Cardiol

From Bioblast
Journals in Bioblast
Journal title and website JAMA Cardiology

Publications

 ReferencePublishedView
Scandalis 2023 JAMA CardiolScandalis L, Kitzman DW, Nicklas BJ, Lyles M, Brubaker P, Nelson MB, Gordon M, Stone J, Bergstrom J, Neufer PD, Gnaiger E, Molina AJA (2023) Skeletal muscle mitochondrial respiration and exercise intolerance in patients with heart failure with preserved ejection fraction. JAMA Cardiol 8:575–84. https://doi.org/10.1001/jamacardio.2023.09572023PMID: 37163294 Open Access Β»O2k-brief
Molina 2023 JAMA CardiolMolina AJA, Gnaiger E, Kitzman DW (2023) Mitochondrial respiration and exercise performance in patients with heart failure with preserved ejection fraction-reply. JAMA Cardiol 8:1101-2. https://doi.org/10.1001/jamacardio.2023.35772023PMID: 37819648
Murthy 2020 JAMA CardiolMurthy VL, Xia R, Baldridge AS, Carnethon MR, Sidney S, Bouchard C, Sarzynski MA, Lima JAC, Lewis GD, Shah SJ, Fornage M, Shah RV (2020) Polygenic risk, fitness, and obesity in the Coronary Artery Risk Development In Young Adults (CARDIA) study. JAMA Cardiol 5:40-8. doi: 10.1001/jamacardio.2019.52202020PMID: 31913407 Open Access
Corlin 2020 JAMA CardiolCorlin Laura, Short Meghan I, Vasan Ramachandran S, Xanthakis Vanessa (2020) Association of the duration of ideal cardiovascular health through adulthood with cardiometabolic outcomes and mortality in the Framingham offspring study. JAMA Cardiol Published online March 11, 2020.2020PMID: 32159731
Fumagalli 2019 JAMA CardiolFumagalli C, Maurizi N, Day SM, Ashley EA, Michels M, Colan SD, Jacoby D, Marchionni N, Vincent-Tompkins J, Ho CY, Olivotto I, SHARE Investigators (2019) Association of obesity with adverse long-term outcomes in hypertrophic cardiomyopathy. JAMA Cardiol 2019 Nov 6:1-8. doi: 10.1001/jamacardio.2019.4268.2019PMID: 31693057
Cookies help us deliver our services. By using our services, you agree to our use of cookies.